These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

448 related items for PubMed ID: 17875728

  • 21. Forced overexpression of either of the two common human Foxp3 isoforms can induce regulatory T cells from CD4(+)CD25(-) cells.
    Aarts-Riemens T, Emmelot ME, Verdonck LF, Mutis T.
    Eur J Immunol; 2008 May; 38(5):1381-90. PubMed ID: 18412171
    [Abstract] [Full Text] [Related]

  • 22. Relationships between regulatory T cells and CD8+ effector populations in patients with squamous cell carcinoma of the head and neck.
    Chikamatsu K, Sakakura K, Whiteside TL, Furuya N.
    Head Neck; 2007 Feb; 29(2):120-7. PubMed ID: 17103408
    [Abstract] [Full Text] [Related]

  • 23. Myeloid differentiation treatment to diminish the presence of immune-suppressive CD34+ cells within human head and neck squamous cell carcinomas.
    Young MR, Wright MA, Pandit R.
    J Immunol; 1997 Jul 15; 159(2):990-6. PubMed ID: 9218621
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. IL-27 inhibits the development of regulatory T cells via STAT3.
    Huber M, Steinwald V, Guralnik A, Brüstle A, Kleemann P, Rosenplänter C, Decker T, Lohoff M.
    Int Immunol; 2008 Feb 15; 20(2):223-34. PubMed ID: 18156621
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Interleukin-21 triggers both cellular and humoral immune responses leading to therapeutic antitumor effects against head and neck squamous cell carcinoma.
    Nakano H, Kishida T, Asada H, Shin-Ya M, Shinomiya T, Imanishi J, Shimada T, Nakai S, Takeuchi M, Hisa Y, Mazda O.
    J Gene Med; 2006 Jan 15; 8(1):90-9. PubMed ID: 16097036
    [Abstract] [Full Text] [Related]

  • 30. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.
    Chaput N, Louafi S, Bardier A, Charlotte F, Vaillant JC, Ménégaux F, Rosenzwajg M, Lemoine F, Klatzmann D, Taieb J.
    Gut; 2009 Apr 15; 58(4):520-9. PubMed ID: 19022917
    [Abstract] [Full Text] [Related]

  • 31. Cyclooxygenase-2 inhibition suppresses alphavbeta6 integrin-dependent oral squamous carcinoma invasion.
    Nystrom ML, McCulloch D, Weinreb PH, Violette SM, Speight PM, Marshall JF, Hart IR, Thomas GJ.
    Cancer Res; 2006 Nov 15; 66(22):10833-42. PubMed ID: 17108119
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. LPS-activated monocytes suppress T-cell immune responses and induce FOXP3+ T cells through a COX-2-PGE2-dependent mechanism.
    Bryn T, Yaqub S, Mahic M, Henjum K, Aandahl EM, Taskén K.
    Int Immunol; 2008 Feb 15; 20(2):235-45. PubMed ID: 18156149
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Presence of membrane-bound TGF-beta1 and its regulation by IL-2-activated immune cell-derived IFN-gamma in head and neck squamous cell carcinoma cell lines.
    Ahn YO, Lee JC, Sung MW, Heo DS.
    J Immunol; 2009 May 15; 182(10):6114-20. PubMed ID: 19414763
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Generation of highly suppressive adaptive CD8(+)CD25(+)FOXP3(+) regulatory T cells by continuous antigen stimulation.
    Mahic M, Henjum K, Yaqub S, Bjørnbeth BA, Torgersen KM, Taskén K, Aandahl EM.
    Eur J Immunol; 2008 Mar 15; 38(3):640-6. PubMed ID: 18266270
    [Abstract] [Full Text] [Related]

  • 40. Activin a promotes the TGF-beta-induced conversion of CD4+CD25- T cells into Foxp3+ induced regulatory T cells.
    Huber S, Stahl FR, Schrader J, Lüth S, Presser K, Carambia A, Flavell RA, Werner S, Blessing M, Herkel J, Schramm C.
    J Immunol; 2009 Apr 15; 182(8):4633-40. PubMed ID: 19342638
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.